Clinical Study of U01ssCART-19 in Patients With B-Cell Lymphoma
Status:
RECRUITING
Trial end date:
2029-01-31
Target enrollment:
Participant gender:
Summary
This is a single-arm, open-label clinical study evaluating the efficacy and safety of U01 (ssCART-19) in patients with relapsed or refractory B-cell lymphoma.